Financial Year |
March 31 2023 |
Monetary Funds |
178,489,502.19 |
Held-for-trading Financial Assets |
403,075,632.48 |
Notes Receivable |
19,114,270.74 |
Accounts Receivable |
102,868,961.41 |
Advances to Suppliers |
17,685,469.92 |
Other Receivables |
7,513,465.97 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
166,468,792.14 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
708,823,463.53 |
Total Current Assets |
1,604,039,558.38 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
12,968,991.84 |
Investment Properties |
16,895,083.62 |
Fixed Assetes |
51,129,958.31 |
Under-construction Projects |
316,001,634.63 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
46,556,459.19 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
14,359,833.22 |
Deferred Income Tax Assets |
14,047,163.31 |
Other Non-Current Assets |
428,477,990.38 |
Sub-Total of Non-Current Assets |
979,659,197.31 |
Total Assets |
2,583,698,755.69 |
Short-Term Loans |
9,041,628.17 |
Trading Financial liabilities |
-- |
Notes Payable |
37,644,817.71 |
Accounts Payable |
97,086,669.71 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
9,893,302.00 |
Taxes Payable |
1,607,156.45 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
655,824.29 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
14,203,988.35 |
Other Current Liabilities |
655,340.94 |
Sub-Total of Current Liabilities |
205,549,613.55 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
9,353,451.22 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
74,260,252.90 |
Total Liabilities |
279,809,866.45 |
Paid-In Capital(Or Share Stock) |
114,896,465.00 |
Capital Surplus |
1,790,868,867.41 |
Surplus Reserve |
45,884,567.77 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
351,635,593.30 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,303,888,889.24 |
Owner's Equity(Stockholder's Equity) |
2,303,888,889.24 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,583,698,755.69 |